Moreover, the ε4 isoform of Apolipoprotein E (Apo E4), which inhibits proteolytic degradation of Aβ, has also been implicated as a significant genetic risk factor for the sporadic AD (Mulder et al., 2014; Johnson, 2020). The gene discussed is APOE; the disease is Alzheimer disease.